SC 13G/A: Prelude Therapeutics Inc
Ticker: PRLD · Form: SC 13G/A · Filed: Feb 13, 2024 · CIK: 1678660
Sentiment: neutral
Topics: sc-13g-a
AI Summary
SC 13G/A filing by Prelude Therapeutics Inc.
Risk Assessment
Risk Level: low
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on February 13, 2024 regarding Prelude Therapeutics Inc (PRLD).